$2 / month

Comment and reply across TML.

Start or manage membership

Most pulsed

Latest from other desks

tml.the modern leap
Health / Medical Research

Brain Pressure Condition Rises Sevenfold In Victorian Adults

A 14-year population study from Monash University and The Alfred, published in the Journal of Neurology, found idiopathic intracranial hypertension rose sevenfold in Victorian adults from 2010 to 2023 and 32-fold in women aged 18 to 39, and the authors say obesity trends alone cannot explain the climb.

TML Health DeskNov 18, 7:52 AM ET · 2 min read

Edited and fact-checked by Stephen Sprague

A sagittal MRI of a human head (archive). Photo: everyone's idle, CC BY 2.0, via Wikimedia Commons.
Summary

The Alfred's IIH clinic trial reads out next, testing endocrine and weight loss drugs against a pressure problem that acetazolamide only partly answers.

Tap a passage. React to the part that matters.

A Victorian woman in her twenties with a persistent headache is far more likely to receive a diagnosis than she was in 2010. Researchers at Monash University and The Alfred Hospital counted cases of idiopathic intracranial hypertension, or IIH, across 14 years of records from Victoria's quaternary referral centers, adult incidence rose sevenfold between 2010 and 2023, and the study appeared in the Journal of Neurology and was announced on November 18.

IIH is raised pressure around the brain with no structural cause and normal spinal fluid composition, and its symptoms are headache, blurred vision, brief losses of vision, pulsatile tinnitus that patients describe as whooshing or thumping in the ears, and trouble with attention and concentration. Untreated, the condition can threaten sight, although permanent visual loss remains uncommon, and doctors have documented it for about 130 years without settling its cause.

Incidence in women aged 18 to 39 rose 32-fold over the study period, and at the 2022 peak women accounted for nine in 10 patients, while cases in children tripled across the same years. First author Dr. Mina Botrous of Monash's School of Translational Medicine found the children's pattern looked different from the adults' pattern, because children presented more often with double vision, recorded higher brain pressures on lumbar puncture, and were far less likely to be obese.

Senior author Professor Anneke van der Walt, an academic neurologist at Monash and director of the MS, Neuroimmunology and Neuro-ophthalmology Unit at The Alfred, said obesity cannot carry the whole explanation. "Obesity is a well-established risk factor for this condition, and the obesity rates in Australia have climbed," she said. "However, they have climbed gradually, and what we are seeing here is much steeper than that." Better recognition and better access to imaging explain part of the rise and do not account for all of it, she said, and the team's candidate mechanisms include hormonal changes around puberty and signals from fat tissue that drive inflammation and alter how brain fluid is made or absorbed.

Most patients take medication to lower the pressure, acetazolamide is the first drug for about seven in 10 adults, and surgery was needed in 6 percent of adults and 12 percent of children in the study cohort. A trial at The Alfred's IIH clinic is testing drugs used for other endocrine conditions alongside new weight loss drugs as a less invasive option, and van der Walt named the research gap directly when she said a condition that overwhelmingly affects young women and is bound up with weight has been slow to attract funding. That funding history, she said, is why the team still cannot tell a 25-year-old exactly why it happened to her.

Sources

The conversation

A little more perspective.

Reading is free. Verified members can comment and reply for $2 a month.

The conversation.

Loading comments…

Keep your curiosity going.

Some links here are affiliate links. If you buy through one, we might make a commission — it never changes what you pay. As an Amazon Associate I earn from qualifying purchases.